Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects-Reference-Cited by-同舟云学术

Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects

Published:2017-09-04 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gomez-Sanchez Clara I.,Carballo Juan J.,Riveiro-Alvarez Rosa,Soto-Insuga Victor,Rodrigo Maria,Mahillo-Fernandez Ignacio,Abad-Santos Francisco^ORCID,Dal-Ré Rafael,Ayuso Carmen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-10912-y.pdf

Reference54 articles.

1. Polanczyk, G. et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164(6), 942 (2007).

2. Faraone, S. V., Biederman, J. & Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36(2), 159 (2006).

3. Sibley, M. H. et al. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry (2016).

4. Spencer, T. J. ADHD and comorbidity in childhood. J Clin Psychiatry 67(Suppl 8), 27 (2006).

5. Biederman, J., Newcorn, J. & Sprich, S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148(5), 564 (1991).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder;European Journal of Clinical Pharmacology;2024-08-19

2. Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis;International Journal of Molecular Sciences;2023-08-19

3. Pharmacogenomics in Psychiatric Diseases;Pharmacogenomics in Clinical Practice;2023

4. Efficacy of Cognitive Behavioral Therapy and Methylphenidate in the Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: A Systematic Review;Cureus;2022-12-17

5. CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders;Pharmacogenomics and Personalized Medicine;2022-11